OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of ketamine administration on the phosphorylation levels of CREB and TrKB and on oxidative damage after infusion of MEK inhibitor
Gislaine Z. Réus, Helena M. Abaleira, Stephanie E. Titus, et al.
Pharmacological Reports (2015) Vol. 68, Iss. 1, pp. 177-184
Closed Access | Times Cited: 21

Showing 21 citing articles:

VGF function in depression and antidepressant efficacy
Cheng Jiang, Wei‐Jye Lin, Masato Sadahiro, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 7, pp. 1632-1642
Open Access | Times Cited: 103

New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Analı́a Bortolozzi, Giovanna Fico, Michael Berk, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 323-357
Open Access | Times Cited: 9

Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction
Claudia Cristiano, Mariarosaria Cuozzo, Lorena Coretti, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113528-113528
Closed Access | Times Cited: 32

The Mechanisms Behind Rapid Antidepressant Effects of Ketamine: A Systematic Review With a Focus on Molecular Neuroplasticity
Melody J.Y. Kang, Emily R. Hawken, Gustavo Vázquez
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 31

An insight into crosstalk among multiple signalling pathways contributing to the pathophysiology of PTSD and depressive disorders
Sumadhura ‬‬‬‬‬‬‬Bommaraju, Mrunali D. Dhokne, E.V. Arun, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110943-110943
Closed Access | Times Cited: 4

Therapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models
Guowei Gong, Yaqun Liu, Zhenxia Zhang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 4
Open Access

Ketamine administered pregnant rats impair learning and memory in offspring via the CREB pathway
Xinran Li, Cen Guo, Yanan Li, et al.
Oncotarget (2017) Vol. 8, Iss. 20, pp. 32433-32449
Open Access | Times Cited: 39

Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine
Samuel Kohtala, Okko Alitalo, Marko Rosenholm, et al.
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107741-107741
Open Access | Times Cited: 31

Ketamine and Calcium Signaling—A Crosstalk for Neuronal Physiology and Pathology
Malwina Lisek, Ludmiła Żylińska, Tomasz Boczek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8410-8410
Open Access | Times Cited: 27

Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression
J. Blair Price, Clarissa Yates, Brooke A. Morath, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 15

Mechanism of synergistic action on behavior, oxidative stress and inflammation following co-treatment with ketamine and different antidepressant classes
Gislaine Z. Réus, Beatriz I. Matias, Amanda L. Maciel, et al.
Pharmacological Reports (2017) Vol. 69, Iss. 5, pp. 1094-1102
Closed Access | Times Cited: 18

General anesthetic neurotoxicity in the young: Mechanism and prevention
Chao Ji, Qiang Ni, Wurong Chen, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 883-896
Closed Access | Times Cited: 13

Insights into the neurobiology of suicidality: explicating the role of glutamatergic systems through the lens of ketamine
Adem Can, Jules Mitchell, Megan Dutton, et al.
Psychiatry and Clinical Neurosciences (2023) Vol. 77, Iss. 10, pp. 513-529
Open Access | Times Cited: 4

Depressive-like behavior accompanies neuroinflammation in an animal model of bipolar disorder symptoms induced by ouabain
Samira S. Valvassori, Jorge M. Aguiar‐Geraldo, Taise Possamai‐Della, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 219, pp. 173434-173434
Open Access | Times Cited: 7

Maternal Deprivation☆
Zuleide Maria Ignácio, Gislaine Z. Réus, João Quevedo, et al.
Elsevier eBooks (2016)
Closed Access | Times Cited: 6

A Brain Signaling Framework for Stress-Induced Depression and Ketamine Treatment Elucidated by Phosphoproteomics
Yan Xiao, Huoqing Luo, Wen Z. Yang, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 6

Antidepressant-like activity of red wine phenolic extracts in repeated corticosterone-induced depression mice via BDNF/TrkB/CREB signaling pathway
Ying Jia, Ziyuan Dong, Tingxu Yan, et al.
BIO Web of Conferences (2016) Vol. 7, pp. 04009-04009
Open Access | Times Cited: 4

Neuroprotective roles of neurotrophic growth factors in mood disorders
Cheng Jiang, Stephen R. Salton
Elsevier eBooks (2019), pp. 145-172
Closed Access | Times Cited: 2


Fatma Tannich, Sonia Hamlaoui, Ouajdi Souilem
Issues in Biological Sciences and Pharmaceutical Research (2020) Vol. 7, Iss. 5
Open Access | Times Cited: 1

The Efficacy of Low-Dose Esketamine and Butorphanol in Treating Depression and Pain After Cesarean Section
Chunyan Zhao, Xiaofen Liu, Cibo Chen, et al.
Advances in Obstetrics and Gynecology Research (2023) Vol. 1, Iss. 3, pp. 57-64
Open Access

Page 1

Scroll to top